Literature DB >> 23132045

The scavenging of volatile anesthetic agents in the cardiovascular intensive care unit environment: a technical report.

Thomas Pickworth1, Angela Jerath, Rita DeVine, Nazmin Kherani, Marcin Wąsowicz.   

Abstract

PURPOSE: The use of volatile-based sedation within critical care environments has been limited by difficulties of drug administration and safety concerns over environment pollution and staff exposure in an intensive care unit (ICU) with no scavenging. The aim of this study was to develop a simple scavenging system to be used with the Anesthesia Conserving Device (AnaConDa(®)) and to determine whether or not ambient concentrations of residual anesthetic are within current acceptable limits. TECHNICAL FEATURES: The scavenging system consists of two Deltasorb(®) canisters attached to the ICU ventilator in series. AnaConDa is a miniature vaporizer designed to provide volatile-based sedation within an ICU. The first ten patients recruited into a larger randomized trial assessing outcomes after elective coronary graft bypass surgery were sedated within the cardiac ICU using either isoflurane or sevoflurane. Sedation was guided by the Sedation Agitation Scale, resulting in an end-tidal minimum anesthetic concentration of volatile agent ranging from 0.1-0.3. At one hour post ICU admission, infrared photometric analysis was used to assess environmental contamination at four points along the ventilator circuit and scavenging system and around the patient's head. All measurements taken within the patient's room were below 1 part per million, which satisfies criteria for occupational exposure.
CONCLUSIONS: This study shows that volatile agents can be administered safely within critical care settings using a simple scavenging system. Our scavenging system used in conjunction with the AnaConDa device reduced the concentration of environmental contamination to a level that is acceptable to Canadian standards and standards in most Western countries and thus conforms to international safety standards. The related clinical trial was registered at www.clinicaltrials.gov (NCT01151254).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23132045     DOI: 10.1007/s12630-012-9814-5

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  9 in total

1.  Does occupational exposure to anesthetic gases lead to increase of pro-inflammatory cytokines?

Authors:  Maurício Martins Chaoul; José Reinaldo C Braz; Lorena Mendes C Lucio; Márjorie A Golim; Leandro Gobbo Braz; Mariana Gobbo Braz
Journal:  Inflamm Res       Date:  2015-09-26       Impact factor: 4.575

2.  Uncontrolled delivery of liquid volatile anaesthetic when using the anaesthetic conserving device.

Authors:  Igor Karnjuš; Dušan Mekiš; Miljenko Križmarić
Journal:  J Clin Monit Comput       Date:  2017-05-31       Impact factor: 2.502

Review 3.  Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review.

Authors:  Jennifer Herzog-Niescery; Hans-Martin Seipp; Thomas Peter Weber; Martin Bellgardt
Journal:  J Clin Monit Comput       Date:  2017-08-31       Impact factor: 2.502

Review 4.  Waste anesthetic gas exposure and strategies for solution.

Authors:  Hai-Bo Deng; Feng-Xian Li; Ye-Hua Cai; Shi-Yuan Xu
Journal:  J Anesth       Date:  2018-02-05       Impact factor: 2.078

5.  Volatile Isoflurane in Critically Ill Coronavirus Disease 2019 Patients-A Case Series and Systematic Review.

Authors:  Armin Niklas Flinspach; Kai Zacharowski; Deligiannis Ioanna; Elisabeth Hannah Adam
Journal:  Crit Care Explor       Date:  2020-10-21

6.  Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice.

Authors:  Jose Miguel Marcos-Vidal; María Merino; Rafael González; Cristina García; Saleta Rey; Irene Pérez
Journal:  J Clin Monit Comput       Date:  2019-02-19       Impact factor: 2.502

7.  The use of volatile anesthetic agents for long-term critical care sedation (VALTS): study protocol for a pilot randomized controlled trial.

Authors:  Angela Jerath; Niall D Ferguson; Andrew Steel; Duminda Wijeysundera; John Macdonald; Marcin Wasowicz
Journal:  Trials       Date:  2015-12-09       Impact factor: 2.279

8.  Sedation with sevoflurane in postoperative cardiac surgery: influence on troponin T and creatinine values.

Authors:  J M Marcos-Vidal; R González; C Garcia; C Soria; M Galiana; B De Prada
Journal:  Heart Lung Vessel       Date:  2014

Review 9.  A technical review of the history, development and performance of the anaesthetic conserving device "AnaConDa" for delivering volatile anaesthetic in intensive and post-operative critical care.

Authors:  Ron Farrell; Glen Oomen; Pauric Carey
Journal:  J Clin Monit Comput       Date:  2018-01-31       Impact factor: 2.502

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.